Reviewer #2 (Public Review): Nifuroxazide enhances radiotherapy efficacy against hepatocellular carcinoma by upregulating PD-L1 degradation via the ubiquitin-proteasome pathway
Tiesuo Zhao(Henan Medical University), Huijie Jia(Henan Medical University)
Cited by 0
Related Papers
The enhanced antitumour response of pimozide combined with the IDO inhibitor L‑MT in melanoma
|International Journal of Oncology|2018|34
Therapeutic effects of STAT3 inhibition by nifuroxazide on murine acute graft graft-vs.-host disease: Old drug, new use
|Molecular Medicine Reports|2017|19
Nifuroxazide suppresses PD-L1 expression and enhances the efficacy of radiotherapy in hepatocellular carcinoma
|eLife|2023|12
Nifuroxazide Suppresses PD-L1 Expression and Enhances the Efficacy of Radiotherapy in Hepatocellular Carcinoma
|bioRxiv (Cold Spring Harbor Laboratory)|2023|2